vs
Side-by-side financial comparison of Bunge Global (BG) and Moolec Science SA (MLEC). Click either name above to swap in a different company.
Bunge Global is the larger business by last-quarter revenue ($4.9B vs $2.6M, roughly 1849.1× Moolec Science SA). Bunge Global runs the higher net margin — 1.9% vs -91.8%, a 93.8% gap on every dollar of revenue.
Bunge Global SA (BUN-ghee) is a global agribusiness and food company, incorporated in Geneva, Switzerland and headquartered in St. Louis, Missouri, United States.
Moolec Science SA is a global agricultural biotechnology and food technology company specializing in molecular farming. It uses engineered crop platforms to produce sustainable, cost-competitive animal-derived proteins for use in alternative meat, dairy products and food ingredients, serving food manufacturers, agribusinesses and consumer goods brands across North America, Europe and Latin America.
BG vs MLEC — Head-to-Head
Income Statement — Q4 2025 vs Q2 2025
| Metric | | |
|---|---|---|
| Revenue | $4.9B | $2.6M |
| Net Profit | $95.0M | $-2.4M |
| Gross Margin | 20.7% | -25.5% |
| Operating Margin | 1.8% | -77.9% |
| Net Margin | 1.9% | -91.8% |
| Revenue YoY | 22.2% | — |
| Net Profit YoY | -84.2% | — |
| EPS (diluted) | $-0.02 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.9B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.0B | — | ||
| Q1 25 | $3.7B | — | ||
| Q4 24 | $4.0B | $2.6M | ||
| Q3 24 | $3.9B | — | ||
| Q2 24 | $3.7B | — | ||
| Q1 24 | $3.9B | — |
| Q4 25 | $95.0M | — | ||
| Q3 25 | $166.0M | — | ||
| Q2 25 | $354.0M | — | ||
| Q1 25 | $201.0M | — | ||
| Q4 24 | $602.0M | $-2.4M | ||
| Q3 24 | $221.0M | — | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $244.0M | — |
| Q4 25 | 20.7% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 16.3% | — | ||
| Q4 24 | 27.0% | -25.5% | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 17.8% | — | ||
| Q1 24 | 22.2% | — |
| Q4 25 | 1.8% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 18.3% | -77.9% | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 9.4% | — |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 8.8% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 15.0% | -91.8% | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 6.2% | — |
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $2.61 | — | ||
| Q1 25 | $1.48 | — | ||
| Q4 24 | $4.27 | $-0.06 | ||
| Q3 24 | $1.56 | — | ||
| Q2 24 | $0.48 | — | ||
| Q1 24 | $1.68 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.0B | $1.9M |
| Total DebtLower is stronger | $10.2B | — |
| Stockholders' EquityBook value | $15.9B | $2.8M |
| Total Assets | $44.5B | $31.4M |
| Debt / EquityLower = less leverage | 0.64× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $7.1B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $3.8B | $1.9M | ||
| Q3 24 | $3.0B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $3.1B | — |
| Q4 25 | $10.2B | — | ||
| Q3 25 | $11.1B | — | ||
| Q2 25 | $7.7B | — | ||
| Q1 25 | $5.4B | — | ||
| Q4 24 | $5.4B | — | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $4.1B | — | ||
| Q1 24 | $4.1B | — |
| Q4 25 | $15.9B | — | ||
| Q3 25 | $15.8B | — | ||
| Q2 25 | $10.9B | — | ||
| Q1 25 | $10.6B | — | ||
| Q4 24 | $9.9B | $2.8M | ||
| Q3 24 | $10.1B | — | ||
| Q2 24 | $10.0B | — | ||
| Q1 24 | $10.6B | — |
| Q4 25 | $44.5B | — | ||
| Q3 25 | $46.3B | — | ||
| Q2 25 | $31.2B | — | ||
| Q1 25 | $26.7B | — | ||
| Q4 24 | $24.9B | $31.4M | ||
| Q3 24 | $25.3B | — | ||
| Q2 24 | $24.4B | — | ||
| Q1 24 | $25.8B | — |
| Q4 25 | 0.64× | — | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | 0.39× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3B | — |
| Free Cash FlowOCF − Capex | $809.0M | — |
| FCF MarginFCF / Revenue | 16.6% | — |
| Capex IntensityCapex / Revenue | 11.0% | 4.4% |
| Cash ConversionOCF / Net Profit | 14.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-879.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | — | ||
| Q3 25 | $854.0M | — | ||
| Q2 25 | $-1.1B | — | ||
| Q1 25 | $-285.0M | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $-1.5B | — | ||
| Q1 24 | $994.0M | — |
| Q4 25 | $809.0M | — | ||
| Q3 25 | $385.0M | — | ||
| Q2 25 | $-1.5B | — | ||
| Q1 25 | $-595.0M | — | ||
| Q4 24 | $564.0M | — | ||
| Q3 24 | $973.0M | — | ||
| Q2 24 | $-1.8B | — | ||
| Q1 24 | $758.0M | — |
| Q4 25 | 16.6% | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | -36.8% | — | ||
| Q1 25 | -16.2% | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | -47.4% | — | ||
| Q1 24 | 19.2% | — |
| Q4 25 | 11.0% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 12.2% | 4.4% | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 8.0% | — | ||
| Q1 24 | 6.0% | — |
| Q4 25 | 14.18× | — | ||
| Q3 25 | 5.14× | — | ||
| Q2 25 | -3.03× | — | ||
| Q1 25 | -1.42× | — | ||
| Q4 24 | 1.75× | — | ||
| Q3 24 | 6.00× | — | ||
| Q2 24 | -21.06× | — | ||
| Q1 24 | 4.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BG
| Other Oilseeds Processing And Refining | $4.6B | 95% |
| Other | $251.0M | 5% |
| Other Products | $3.0M | 0% |
MLEC
Segment breakdown not available.
